期刊文献+

益气养阴活血法联合二甲双胍治疗2型糖尿病的临床疗效 被引量:4

Analysis of curative effect of Yiqi Yangyin Huoxue Decoction combined with metformin in treatment of type 2 diabetes mellitus
原文传递
导出
摘要 目的研究并分析应用益气养阴活血法联合二甲双胍治疗2型糖尿病的临床疗效。方法选择本院2013年5月至2015年4月期间2型糖尿病患者共200例,按照随机数字表法分为试验组和对照组各100例,对照组给予二甲双胍治疗,试验组则应用益气养阴活血法联合二甲双胍治疗,观察并比较两组患者治疗前后的临床疗效。结果两组患者治疗前后相比较,试验组患者相比于对照组患者空腹血糖、餐后2 h血糖、糖化血红蛋白、24 h尿蛋白量等指标明显改善,两组结果比较差异有统计学意义(P<0.05);并且总胆固醇、甘油三酯、血肌酐、血尿素氮等指标明显降低,两组结果比较差异有统计学意义(P<0.05)。结论应用益气养阴活血法联合二甲双胍治疗2型糖尿病,临床效果显著,值得推广。 Objective To study the clinical efficacy and application of Yiqi Yangyin Huoxue Decoction combined with metformin in treatment of type 2 diabetes mellitus. Methods 200 type 2 diabetes patients were selected and randomly divided according to the random number table method into the experimental group and the control group; the control group was given metformin, the experimental group with Yiqi Yangyin Huoxue Decoction combined with metformin.Results The two groups of patients before and after treatment were compared. The patients in the experimental group had obvious improvement in fasting blood glucose, postprandial 2H plasma glucose, glycosylated hemoglobin, 24 h urine protein amount index than those of control group(P 〈0.05). The total cholesterol, glycerin three esters, serum creatinine, blood and urine nitrogen index decreased significantly; the differences between the two groups were significant(P0.05). Conclusion The application of Yiqi Yangyin Huoxue Decoction combined with metformin in the treatment of type 2 diabetes has a significant clinical effect, and worthy of promotion.
出处 《热带医学杂志》 CAS 2016年第8期1040-1042,共3页 Journal of Tropical Medicine
基金 湛江市科技计划项目(2015B01103)
关键词 益气养阴活血法 二甲双胍 2型糖尿病 Bvqnyabc Metformin Type 2 diabetes mellitus
  • 相关文献

参考文献12

二级参考文献64

  • 1崔宇晨.补肾活血方治疗早期糖尿病肾病60例[J].河北中医,2005,27(2):99-99. 被引量:10
  • 2范建高,李新建,朱军,李锐,戴菲,宋晓敏,刘天舒,陈兰,李锋.上海市成人代谢综合征与脂肪肝关系分析[J].中华内分泌代谢杂志,2005,21(4):306-309. 被引量:81
  • 3杨霓芝,刘旭生.糖尿病肾病诊断、辨证分型及疗效评定标准(试行方案)[J].上海中医药杂志,2007,41(7):7-8. 被引量:1183
  • 4陈灏珠.实用内科学[M].北京:人民卫生出版社,2009.
  • 5PATRICK L. Nonalcoholic fatty liver disease, relationship to insu- lin sensitivity and oxidative stress. Treatment approaches using vi- tamin E, magnesium, and betaine[ J]. Altern Med Rev, 2002, 7 (4) : 276 -291.
  • 6KELLEY D E, MCKOLANIS T M, HEGAZI R A, et al. Fatty liv- er in type 2 diabetes mellitus, relation to regional adiposity, fatty acids, and insulin resistance[ J]. Am J Physiol Endocrinol Metab, 2003, 285(4) : E906 - E916.
  • 7MARCHESINI G, BUGIANESI E, FORLANI G, et al. Nonalco- holic fatty liver, steatohepatitis, and the metabolic syndrome [ J ]. Hepatology, 2003, 37(4): 917-923.
  • 8HANLEY A J, WILLIAMS K, FESTA A, et al. Elevations in markers of liver injury and risk of type 2 diabetes, the insulin resistance ather- osclerosis study[J]. Diabetes, 2004, 53( 10): 2623-2632.
  • 9TOMITA K, OIKE Y, TERATANI T, et al. Hepatic AdipoR2 signa- ling plays a protective role against progression of nonalcoholic steato- hepatitis in mice[J]. Hepatology, 2008, 48(2) : 458 -473.
  • 10CHU S H, LEE M K, AHN K Y, et al. Chemerin and adiponectin contribute reciprocally to metabolic syndrome [ J ]. PLoS One, 2012, 7(4) : e34710.

共引文献112

同被引文献38

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部